FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY
A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disord...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
06.02.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 5,7,8,15-tetrahydro-6H-8,15- methanobenzimidazo[1,2-b][2,5]benzodiazocin-6-one derivatives and analogs thereof. |
---|---|
AbstractList | A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 5,7,8,15-tetrahydro-6H-8,15- methanobenzimidazo[1,2-b][2,5]benzodiazocin-6-one derivatives and analogs thereof. |
Author | KEYAERTS, Jean HEER, Jag Paul |
Author_xml | – fullname: KEYAERTS, Jean – fullname: HEER, Jag Paul |
BookMark | eNrjYmDJy89L5WRwdQsNdnVRCHD1C3F0jnT28XRW8PT1dHGM8vdxVXBxDfIMcwzxDHMNVnAMVvD1dwn1cQzxDwpW8HdTCPFzU3B0Bkp6hkTyMLCmJeYUp_JCaW4GBTfXEGcP3dSC_PjU4oLE5NS81JJ41wBjE2MzE1MLR0NjIpQAAGD1LaY |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | DÉRIVÉS D'IMIDAZOLE PENTACYCLIQUES CONDENSÉS UTILISÉS EN TANT QUE MODULATEURS DE L'ACTIVITÉ DU TNF KONDENSIERTE PENTACYCLISCHE DERIVATE ALS MODULATOREN DER TNF-AKTIVITÄT |
ExternalDocumentID | EP3436458A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP3436458A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:49:13 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP3436458A13 |
Notes | Application Number: EP20170714243 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190206&DB=EPODOC&CC=EP&NR=3436458A1 |
ParticipantIDs | epo_espacenet_EP3436458A1 |
PublicationCentury | 2000 |
PublicationDate | 20190206 |
PublicationDateYYYYMMDD | 2019-02-06 |
PublicationDate_xml | – month: 02 year: 2019 text: 20190206 day: 06 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | UCB Biopharma SPRL SANOFI |
RelatedCompanies_xml | – name: UCB Biopharma SPRL – name: SANOFI |
Score | 3.1864436 |
Snippet | A series of fused pentacyclic imidazole derivatives, being potent modulators of f benefit in the treatment and/or prevention of various human ailments,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190206&DB=EPODOC&locale=&CC=EP&NR=3436458A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dS8Mw8BhT1DedivOLPEjfhs5-rC9DuiRlla4ta1Y2X8bapbCXbmwV_76X0k1f9CUcCRyXg_vKXe4AnlLLXFhGnnVyaSwxQLH1zkLiIlMjM_VeLu1cZXRHgTWcGO9Tc9qA1f4vTNUn9KtqjogSlaG8l5W-3vw8YrGqtnL3nK5wa_3mij7T6ugYrdvri6WxQZ9HIQupRilCWjBGZa3ybbaDgdIRetE9JQw8GahPKZvfFsU9h-MIkRXlBTRk0YJTuh-81oKTUZ3vRrAWvd0lcHcSc0YiHgiHzqjvUYJ6hzkfoc8Jw3AscYSX8Jg4MRmFbOI7IhzHJHSJCFyiakUST8yugLhc0GEH6Zkf7j7n0YFy_RqaxbqQN0BM2zIWuVTt2NAjSLNUTW1ZdvUs7yoXJmtD-080t_-c3cGZYmJVlWzdQ7PcfsoHNLpl-lix6xtrkoCB |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1dT8Iw8ELQiG-KGvGzD2ZvRJFt7IWY0XZhuq-wsoAvhI0u4WUQmfHve10AfdGX5tIml-sl99W73gE8pKYxN_U8a-dSX2CAYnXbc4mLTPXM6PZyaeUqo-sH5nCsv06MSQ2Wu78wVZ_Qr6o5IkpUhvJeVvp6_fOIxarays1jusSt1Ysj-kzbRsdo3Z6fTI0N-jwKWUg1ShHSghEqa5Vvs2wMlA7Qw-4pYeDJQH1KWf-2KM4JHEaIrChPoSaLJjTobvBaE478bb4bwa3obc6AO-OYMxLxQNh0Sj2XEtQ7zH4PPU4YhmOJLdyEx8SOiR-ysWeLcBST0CEicIiqFUlcMT0H4nBBh22kZ7a_-4xHe8q7F1AvVoW8BGJYpj7PpWrHhh5BmqVqasui083yjnJhsha0_kRz9c_ZPTSGwvdmnhu8XcOxYmhVoWzeQL38-JS3aIDL9K5i3Ted_YN0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FUSED+PENTACYCLIC+IMIDAZOLE+DERIVATIVES+AS+MODULATORS+OF+TNF+ACTIVITY&rft.inventor=KEYAERTS%2C+Jean&rft.inventor=HEER%2C+Jag+Paul&rft.date=2019-02-06&rft.externalDBID=A1&rft.externalDocID=EP3436458A1 |